MEDROXYPROGESTERONE A and 1 more item

The Defense Logistics Agency Troop Support Medical Supply Chain is soliciting quotes for two line items of Medroxyprogesterone Acetate, NSN 6505-01-276-2029, under RFQ SPE2DP26T5342, with quotes due October 5, 2026. The Set Aside line reads "No Set-Aside Used," so the procurement is open to all responsible sources.

Delivery is required within 20 days on FOB Destination terms, with inspection at destination. The attached RFQ summary places delivery at Rose Barracks South, Vilseck, Germany. Each line requests one bottle (BT), and quotes must be submitted through DIBBS. The solicitation type is Fast Auto Evaluation, and the attached summary states automated award is possible unless First Article Test requirements apply.

The solicitation requires a minimum 31-month shelf life at receipt, commercial packaging, marking per Medical Marking Standard No. 1, and hazard warning labels compliant with 29 CFR 1910.1200. It incorporates DFARS 252.225-7001 Buy American Act compliance and the DLA Master Solicitation for Automated Simplified Acquisitions Revision 105. The product is 2.5 mg tablets per the attached summary. The PSC is 6505, Drugs and Biologicals, and the attached summary classifies the buy under NAICS 325412 with a 500-employee size standard.

Historical procurement data cited in the attached summary shows CAGE code 00E55 as the consistent supplier across multiple 2025–2026 awards, at unit costs of $3.66 to $4.37 per bottle. The contracting officer is Daniel Porter (DDP0090) at DLA Troop Support, Philadelphia, PA 19111, reachable at 392-737-3149 or DANIEL.PORTER@DLA.MIL.